✦ LIBER ✦

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study

✍ Scribed by S. L. Thrower; L. James; W. Hall; K. M. Green; S. Arif; J. S. Allen; C. Van-Krinks; B. Lozanoska-Ochser; L. Marquesini; S. Brown; F. S. Wong; C. M. Dayan; M. Peakman

Book ID: 108700940
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 298 KB
Volume: 155
Category: Article
ISSN: 0009-9104
DOI: 10.1111/j.1365-2249.2008.03814.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene Electrotransfer of Plasmid Antiangi

Gene Electrotransfer of Plasmid Antiangiogenic Metargidin Peptide (AMEP) in Disseminated Melanoma: Safety and Efficacy Results of a Phase I First-in-Man Study

✍ Spanggaard, Iben; Snoj, Marko; Cavalcanti, Andrea; Bouquet, Céline; Sersa, Grego 📂 Article 📅 2013 🏛 Mary Ann Liebert 🌐 English ⚖ 619 KB

A PHASE I/IIA FIRST IN MAN SAFETY AND TO

A PHASE I/IIA FIRST IN MAN SAFETY AND TOLERABILITY STUDY OF A NOVEL HNO DONOR, CXL-1020, IN PATIENTS WITH STABLE CONGESTIVE HEART FAILURE

✍ Doug Cowart; Juan Aranda; Garrie Haas; Joel Neutel; William Smith; Reza Mazhari; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Tolerability and safety of GS-101 eye dr

Tolerability and safety of GS-101 eye drops, an antisense oligonucleotide to insulin receptor substrate-1: a ‘first in man’ Phase I investigation

✍ Hermann Kain; David Goldblum; Bernard Geudelin; Eric Thorin; Christoph Beglinger 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB

A Double-Blind, Randomized Placebo-Contr

A Double-Blind, Randomized Placebo-Controlled Phase II Study of the Pharmacodynamics, Safety/Tolerability, and Pharmacokinetics of Single Doses of the Motilin Agonist GSK962040, in Patients With Type I Diabetes Mellitus (T1DM) and Gastroparesis

✍ Hellström, Per M. ;Tack, Jan F. ;Stephens, Kimberley E. ;Barton, Matthew E. ;Vas 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 102 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants

✍ David I. Bernstein; Judith Falloon; Tingting Yi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 596 KB

1234 POSTER A First in Man Phase 1 Study

1234 POSTER A First in Man Phase 1 Study of JNJ-26481585, a Novel Oral Histone Deacetylase Inhibitor (HDACi) in Advanced Cancer Patients -Evidence of Target Modulation, Antitumour Activity and Additional Safety Data in an Expanded Patient Cohort

✍ A. Omlin; B. Venugopal; R. Kristeleit; K. Shah; N. Fourneau; P. Hellemans; J. de 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB